US vaccine debate intensifies as CDC director confirmed and mRNA flu shot approved
Solo los hechos

US vaccine debate intensifies as CDC director confirmed and mRNA flu shot approved

Resumen

The confirmation of Dr. Erica Schwartz as CDC director and the FDA's approval of an mRNA flu vaccine have heightened public debate over vaccination amid rising measles cases and declining flu-shot rates.

The U.S. Senate confirmed Dr. Erica Schwartz as the new director of the Centers for Disease Control and Prevention, prompting a New York Times alert that highlighted her support for childhood vaccines. At the same time, the Food and Drug Administration approved Moderna’s mRNA flu vaccine for adults 50 and older, sparking renewed discussion on vaccine safety and efficacy.

Vaccination rates have slipped in recent years, with the CDC reporting that only about half of children and 42% of adults received a flu shot for the 2024-2025 season, the lowest levels in over a decade. Measles cases have risen, resulting in three deaths this year, including two children, and prompting concerns that exemption requests are pushing many states below the 95% coverage threshold health officials consider necessary to prevent outbreaks.

Republican voters remain more skeptical of vaccine safety than Democrats, according to a Pew Research study released in December. Health officials note that the pandemic disrupted routine immunizations, with nearly 40 million children missing a measles dose in 2021, and vaccination rates have not fully recovered.

During a recent interview, Health and Human Services Secretary Robert F. Kennedy Jr. told CNN’s Dana Bash that parents should obtain the MMR vaccine, while also questioning the role of pandemic-related lockdowns in the current measles surge. Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, warned that the public’s memory of diseases like measles has faded, reducing perceived risk.

Critics of the mRNA flu shot, including author Alex Berenson, argue that its trial data show a higher incidence of severe side effects compared with traditional flu vaccines, while Dr. Offit described the new vaccine as a 25% improvement in effectiveness. The FDA’s decision comes as the Trump administration has reduced the recommended childhood vaccine schedule from 17 to 11 doses and issued an executive order to separate the MMR vaccine into three separate shots.

Public-health experts say rebuilding trust will require clear communication through trusted community channels and, according to some, a more emotional portrayal of disease impact. The debate continues as the nation observes National Immunization Awareness Month.

Sigue leyendo, gratis

Crea una cuenta gratis para seguir las noticias. No se requiere tarjeta.